Overview
Kroopa Joshi practices practicing medicine in London, United Kingdom.
Their clinical expertise encompasses Melanoma, Lung Cancer, Muscle Invasive Bladder Cancer, Non-Small Cell Lung Cancer (NSCLC), and Hepato-Pancreato-Biliary Surgery.
They are actively involved in clinical research, co-authoring 28 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kroopa S. Joshi
Is Kroopa S. Joshi a top-rated expert for Hepato-Pancreato-Biliary Surgery?
MediFind is an objective health platform that identifies experts based on real-world data. Kroopa S. Joshi is classified as an Experienced expert for Hepato-Pancreato-Biliary Surgery, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kroopa S. Joshi participate in research or clinical trials?
Yes. Kroopa S. Joshi has published 28 articles and abstracts on conditions like Hepato-Pancreato-Biliary Surgery. You can view a list of Kroopa S. Joshi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hepato-Pancreato-Biliary Surgery
- Lung CancerJoshi isExperienced. Learn about Lung Cancer.
- MelanomaJoshi isExperienced. Learn about Melanoma.
- Muscle Invasive Bladder Cancer
- Non-Small Cell Lung Cancer (NSCLC)